Orion Corporation

Industry

  • Pharmaceuticals
    • Vaccines
    • Generic Drugs
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Digital Health
    • Disease Management
  • Medical Devices
  • Biotechnology

Other Names/Subsidiaries

  • Orion Corporation
  • Orion Diagnostica Oy
  • Orion Pharma
  • Orion Oyj
See more in Biomedtracker

Latest on Orion Corporation

Scrip

Deal Watch: Novo Nordisk, IMMvention To Partner On Sickle Cell Disease

 
• By Joseph Haas, Dexter Jie Yan, Xu Hu, and Vibha Ravi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novo Nordisk, IMMvention Collaboration

Scrip

Vertex’s Journavx Has Non-Opioid Advantage, But Faces Commercial Headwinds

 
• By Alaric DeArment

Vertex Pharmaceuticals’ Journavx (suzetrigine) has gained US Food and Drug Administration approval for acute pain, but the question now is how well it might fare commercially, with analysts forecastin

Scrip

Deal Watch: Merck Decides Better Late Than Never In GLP-1 Deal With Hansoh

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Merck Obtains Global Rights To Hansoh’

Scrip

Eight Recent Deals Tapping AI/ML For R&D

 
• By Joseph Haas

As the improvements made possible with artificial intelligence and machine learning for biopharmaceutical research and development become clear, deal making in the space has skyrocketed. S&P Global pr